COVID-19

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter…

1 year ago

Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board

CHAPEL HILL, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on…

1 year ago

Regional Health Properties Reports Third Quarter 2023 Financial Results

Collected 93% of Contractual Rent Strong Operator Rent Coverage ATLANTA, GA, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Regional Health Properties,…

1 year ago

Global COVID-19 Monument Design Competition Winner Announced

These Frontline workers deserve a monument, Please donate $10 to honor them today! Casey Schachner COVID-19 Monument Design Contest winner…

1 year ago

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023…

1 year ago

UpHealth Enters into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million

Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on…

1 year ago

LCF Georgia Releases Groundbreaking Status of Latino Health Report in Georgia

The Last Report of Its Kind Was Issued a Decade AgoATLANTA, GA / ACCESSWIRE / November 16, 2023 / A…

1 year ago

Gratia Health Emerges From Stealth With ScionHealth Partnership to Support Frontline Caregivers With Its Incentive Compensation Platform

Now live at 70-plus hospitals nationwide, Gratia has supported employees while helping health system reduce contract nursing labor costsAUSTIN, Texas--(BUSINESS…

1 year ago

Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19

U.S. Army-Funded Project Will Support Further Development of Novel Therapeutic ModalityDURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma, a clinical-stage company advancing a proprietary…

1 year ago

FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023

TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

1 year ago